Clinical Study of BR105 Injection

Clinical trial NCT05351697 · TERMINATED

Trial details

NCT number: NCT05351697
Sponsor: BioRay Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2022-04-19
Primary completion: 2025-10-30
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.